Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis

Clin Exp Dermatol. 2011 Oct 10. doi: 10.1111/j.1365-2230.2011.04186.x.
Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.
Zhuo FL, Xu W, Wang L, Wu Y, Xu ZL, Zhao JY.

Department of Dermatology, Beijing Friendship hospital, Capital Medical University, Beijing, China Department of Dermatology, the First Affiliated Hospital, China Medical University, Shenyang, China.

Background.  Numerous studies have shown an association between polymorphisms in the androgen receptor gene (AR) and the risk for androgenetic alopecia (AGA), but the overall results are still controversial. Aim.  To determine, by conducting a meta-analysis, whether the common AR gene polymorphisms confer susceptibility to AGA. Methods.  Publications addressing the association between AR gene polymorphisms and risk for AGA were selected from the PubMed, EMBASE and CBMdisc databases. Data were extracted from the studies by two independent reviewers. The meta-analysis was performed using the software programs RevMan (version 5.0.25) and STATA (version 9.2). From these data, odds ratio (OR) with 95% confidence interval (CI) was calculated. Results.  Only eight studies were found, reporting a total of 2074 patients with AGA and 1115 healthy controls. Three common polymorphisms of the AR gene were addressed: a StuI restriction-site polymorphism (rs6152, G>A), and CAG and GGC triplet-repeat polymorphisms. Meta-analysis results identified a significant association between the G allele of the AR StuI polymorphism and the risk for AGA (OR = 2.68, 95% CI 1.71-4.19, P < 0.01), especially in white populations (OR = 2.76, 95% CI 1.71-4.45, P < 0.01). No association was found between the CAG or GGC polymorphism and the risk for AGA (OR = 0.81, 95% CI 0.49-1.34, P = 0.41; OR = 1.01, 95% CI 0.47-2.14, P = 0.99, respectively). Conclusion.  Our meta-analysis suggests that the G allele of AR StuI polymorphism might be a potential risk factor for AGA, especially in white populations. However, we did not find any obvious association of the CAG and GGC triplet-repeat polymorphisms of the AR gene with risk for AGA.

Someone please translate:P

There's a certain genetic variant of the androgen receptor that predisposes some white people to MPB.

crincrin wrote:There's a certain genetic variant of the androgen receptor that predisposes some white people to MPB.

Would that mean that MPB is harder to treat in those people?

Reminds me of prostate cancer, was found that the genetic variant found in those with this particular cancer is merely an additional immune gene that is used for defensive purpouses. Wonder what the mechanism is behind the variant CS has posted about here is, from my experience everything no matter how incriminating it might seem in the body, has a purpouse.